Product Revenue, Net - U.S was Agios Pharmaceuticals’s largest region in fiscal 2025, bringing in $49.17M of $54.03M (91%).
| Geography | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|
| Product Revenue, Net - U.S | $26.82M | $36.40M | $49.17M |
| Product Revenue, Net - Rest Of World | — | $103.00K | $4.86M |
| Total | $26.82M | $36.50M | $54.03M |
Agios Pharmaceuticals brought in $54.03M from its two regions in fiscal 2025, the year ended December 31, 2025. That was up 48.0% from $36.50M in fiscal 2024. Product Revenue, Net - U.S was the largest at $49.17M (91.0%), ahead of Product Revenue, Net - Rest Of World at $4.86M (9.0%).
Compared with fiscal 2024, Product Revenue, Net - Rest Of World grew 4,616.5% to $4.86M and Product Revenue, Net - U.S grew 35.1% to $49.17M.
Agios Pharmaceuticals began breaking out Product Revenue, Net - Rest Of World in fiscal 2024, when it brought in $103.00K.
Agios Pharmaceuticals (AGIO) reports its revenue by geography. In fiscal 2025, Product Revenue, Net - U.S was its largest region, bringing in $49.17M (91.0% of the total), followed by Product Revenue, Net - Rest Of World at $4.86M (9.0%).
Product Revenue, Net - U.S was Agios Pharmaceuticals' largest region in fiscal 2025, bringing in $49.17M, or 91.0% of the $54.03M total across its two regions.
Product Revenue, Net - Rest Of World grew faster than Product Revenue, Net - U.S in fiscal 2025, up 4,616.5% from $103.00K to $4.86M. Product Revenue, Net - U.S grew 35.1% to $49.17M.
Every figure comes from Agios Pharmaceuticals' annual financial filings, as reported. Each line keeps the name Agios Pharmaceuticals gives it, and years follow its fiscal calendar.
Agios Pharmaceuticals' revenue by geography goes back to fiscal 2023, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.